Sign in to view content

New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases

Alay S. Banker, MD

Video
Published 2018

Related

Endophthalmitis Rates of Prefilled Ranibizumab Syringes Compared to Conventional Ranibizumab Vials: An International Multicenter Study
Yoshihiro Yonekawa, MD, FASRS
Annual Meeting Talks
2018
Outcomes of Repair of Moderately Complex Phakic Rhegmatogenous Retinal Detachment (RRD): The PRO Study (Primary Retinal Detachment Outcomes)
Edwin H. Ryan, MD
Annual Meeting Talks
2018
Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial
Rishi P. Singh, MD
Annual Meeting Talks
2018

Category: Retinal Vascular Disease

See more